United Health Products, Inc.
OTC:UEEC
0.27 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.038 | 0 | 0.001 | 0.005 | 0.046 | 0.646 | 0.242 | 0.053 | 0.163 | 0.003 | 0 | 0 | 0.069 | 0.024 | 0.008 | 0 | 0 | 0 |
| Cost of Revenue
| 0.005 | 0.019 | 0 | 0 | 0.001 | 0.097 | 0.067 | 0.118 | 0.028 | 0.083 | 0 | 0 | 0 | 0.056 | 0.017 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.005 | 0.019 | 0 | 0 | 0.004 | -0.051 | 0.579 | 0.124 | 0.026 | 0.08 | 0.003 | 0 | 0 | 0.013 | 0.007 | 0.008 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.503 | 0.576 | 0.697 | 0.733 | -1.109 | 0.896 | 0.513 | 0.483 | 0.49 | 1 | 0 | 0 | 0.183 | 0.304 | 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.599 | 0.625 | 0.237 | 0.245 | 0.666 | 0.077 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.22 | 0.107 | 0 | 0 | 0.487 | 0.285 | 0.228 | 0.191 | 0.016 |
| Selling & Marketing Expenses
| 1.802 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.823 | 2.196 | 29.563 | 14.604 | 5.431 | 2.25 | 1.298 | 0.642 | 2.608 | 2.122 | 1.22 | 0.107 | 1.217 | 2.547 | 0.487 | 0.285 | 0.228 | 0.191 | 0.016 |
| Other Expenses
| 0 | 1.403 | 0.304 | 0 | 0 | 0.004 | 0 | 0 | 0 | 0.05 | 0.259 | 0.1 | 0.1 | 0.1 | 0.05 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 2.427 | 2.821 | 29.801 | 14.849 | 6.098 | 2.327 | 1.298 | 0.642 | 2.608 | 2.172 | 1.32 | 0.207 | 1.317 | 2.647 | 0.537 | 0.285 | 0.228 | 0.191 | 0.016 |
| Operating Income
| -2.427 | -2.802 | -29.801 | -14.849 | -6.094 | -2.378 | -0.719 | -0.517 | -2.583 | -2.092 | -1.317 | -0.207 | -1.317 | -2.634 | -0.53 | -0.277 | -0.228 | -0.191 | -0.016 |
| Operating Income Ratio
| 0 | -74.721 | -505,095.508 | -23,092.77 | -1,236.881 | -51.842 | -1.114 | -2.138 | -48.487 | -12.861 | -430.296 | 0 | 0 | -38.141 | -22.164 | -33.784 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.197 | 1.115 | -0.749 | -0.863 | -0.508 | -3.505 | -0.216 | -0.018 | -0.009 | -0.052 | 0.19 | -0.074 | -0.271 | -0.261 | -0.38 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -2.623 | -1.688 | -30.549 | -15.711 | -6.602 | -6.006 | -0.935 | -0.536 | -2.592 | -2.144 | -1.126 | -0.281 | -1.588 | -2.896 | -0.91 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0 | -45 | -517,782.763 | -24,434.526 | -1,340.023 | -130.961 | -1.448 | -2.214 | -48.659 | -13.182 | -368.093 | 0 | 0 | -41.922 | -38.071 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.001 | 0.618 | 0.546 | 0.508 | 3.633 | 0.031 | -0.517 | -0.05 | 0 | 0.069 | 0 | 0 | -0.099 | -0.197 | 0.277 | 0.228 | 0.191 | 0.016 |
| Net Income
| -2.623 | -1.686 | -31.167 | -16.258 | -7.11 | -6.006 | -0.935 | -0.536 | -2.592 | -2.144 | -1.126 | -0.281 | -1.588 | -2.896 | -0.91 | -0.277 | -0.228 | -0.191 | -0.016 |
| Net Income Ratio
| 0 | -44.97 | -528,261.593 | -25,284.025 | -1,443.166 | -130.961 | -1.448 | -2.214 | -48.659 | -13.182 | -368.093 | 0 | 0 | -41.922 | -38.071 | -33.784 | 0 | 0 | 0 |
| EPS
| -0.011 | -0.007 | -0.14 | -0.089 | -0.04 | -0.035 | -0.006 | -0.004 | -0.019 | -0.021 | -0.012 | -0.003 | -0.02 | -0.057 | -0.023 | -0.008 | -0.008 | -0.007 | -0 |
| EPS Diluted
| -0.011 | -0.007 | -0.14 | -0.089 | -0.04 | -0.035 | -0.006 | -0.004 | -0.019 | -0.021 | -0.012 | -0.003 | -0.02 | -0.057 | -0.023 | -0.008 | -0.006 | -0.005 | -0 |
| EBITDA
| -2.502 | -1.605 | -0.749 | -0.863 | -6.094 | -5.402 | -0.535 | -0.517 | -2.583 | -2.042 | -1.217 | -0.107 | -1.217 | -2.534 | -0.796 | -0.277 | -0.228 | -0.191 | -0.016 |
| EBITDA Ratio
| 0 | -37.2 | -499,938.339 | -23,092.77 | -1,236.881 | -51.756 | -0.828 | -2.138 | -48.487 | -12.554 | -397.617 | 0 | 0 | -39.3 | -31.711 | -33.784 | 0 | 0 | 0 |